Literature DB >> 10207617

Signal transduction by the c-Jun N-terminal kinase.

R J Davis1.   

Abstract

The c-Jun N-terminal kinase (JNK) group of mitogen-activated protein kinases (MAP kinases) is activated by exposure of cells to environmental stress and by the treatment of cells with cytokines. The mechanism of activation of JNK is mediated by dual phosphorylation within kinase subdomain VIII on the motif Thr-Pro-Tyr. This phosphorylation is mediated by the MAP kinase kinases MKK4 and MKK7. These MAP kinase kinases serve as signalling molecules that integrate a wide array of stimuli into the activation of the JNK signalling pathway. Studies of the physiological function of JNK have been facilitated by the molecular genetic analysis of JNK signalling in Drosophila and by the creation of mice with targeted disruption of components of the JNK pathway. These studies demonstrate that the JNK pathway regulates AP-1 (activator protein-1) transcriptional activity in vivo and indicate that JNK is required for embryonic morphogenesis, the regulation of cellular proliferation and apoptosis, and the response of cells to immunological stimuli.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207617     DOI: 10.1515/9781400865048.1

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  45 in total

1.  MEK5, a new target of the atypical protein kinase C isoforms in mitogenic signaling.

Authors:  M T Diaz-Meco; J Moscat
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 2.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer.

Authors:  Christopher Johnson; Yuyan Han; Nathan Hughart; Jennifer McCarra; Gianfranco Alpini; Fanyin Meng
Journal:  Transl Gastrointest Cancer       Date:  2012-04-01

4.  Measuring the constitutive activation of c-Jun N-terminal kinase isoforms.

Authors:  Ryan T Nitta; Shawn S Badal; Albert J Wong
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

5.  Activation of c-Jun NH2-terminal kinase (JNK) pathway during islet transplantation and prevention of islet graft loss by intraportal injection of JNK inhibitor.

Authors:  H Noguchi; Y Nakai; M Ueda; Y Masui; S Futaki; N Kobayashi; S Hayashi; S Matsumoto
Journal:  Diabetologia       Date:  2007-01-16       Impact factor: 10.122

Review 6.  JNK: a stress-activated protein kinase therapeutic strategies and involvement in Alzheimer's and various neurodegenerative abnormalities.

Authors:  Sidharth Mehan; Harikesh Meena; Deepak Sharma; Rameshwar Sankhla
Journal:  J Mol Neurosci       Date:  2010-09-28       Impact factor: 3.444

7.  A direct interaction between JNK1 and CrkII is critical for Rac1-induced JNK activation.

Authors:  S E Girardin; M Yaniv
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

8.  Functional cooperation between HIF-1α and c-Jun in mediating primary and acquired resistance to gefitinib in NSCLC cells with activating mutation of EGFR.

Authors:  Shuyan Meng; Guorui Wang; Yang Lu; Zhen Fan
Journal:  Lung Cancer       Date:  2018-05-01       Impact factor: 5.705

9.  TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling.

Authors:  You-Sun Kim; Sergei A Nedospasov; Zheng-Gang Liu
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.